Opioid Use Disorder
421
135
179
145
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Published Results
50 trials with published results (12%)
Research Maturity
145 completed trials (34% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.8%
16 terminated out of 421 trials
90.1%
+3.5% vs benchmark
12%
50 trials in Phase 3/4
34%
50 of 145 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 145 completed trials
Clinical Trials (421)
Acceptability and Feasibility of Extended-Release Subcutaneous Buprenorphine on a Mobile Pharmacy Clinic
A Study to Test Whether BI 1356225 Improves Impulsive Behavior in People With Opioid Use Disorder Who Are Taking Buprenorphine
Measuring the Effects of Neurostimulation on Risky and Ambiguous Decision-Making Capacity in People With and Without Substance Use Disorder
iSTEP-N 101b: Pharmacokinetics and Safety Study of Low- and High-Dose Naltrexone Implants vs Monthly Vivitrol in Healthy Volunteers
Adaptive Decision Support for Addiction Treatment (ADAPT) Serial Randomized Testing for Usability, Round 1
Pilot of Mailing Buprenorphine
High Dose Buprenorphine (BUP) Induction in the Emergency Department (ED)
Older Adults, Methadone, and Cognitive Function
Infectious Disease (ID) Testing OUtreach in Carceral Hubs
Adapting the Penny Chatbot for Perinatal OUD Patients: COPILOT
GLP-1R Agonist Treatment for Opioid Use Disorder
Evaluating Buspirone to Treat Opioid Withdrawal
A Clinical Trial of Telehealth Treatment for Opioid Use Disorders
Clinician Practice Companion to Address Youth Substance Use
Behavioral Pharmacological Examination of a Novel Buprenorphine Induction Method Among Individuals Who Use Fentanyl
Developing a Clinical Outcome Assessment for Opioid Craving
Adjunctive Bright Light Therapy for Opioid Use Disorder
Real World Evaluation of the Effectiveness and Implementation of a Digital Health Therapeutic for OUD
Low-dose Buprenorphine Initiation for Opioid Use Disorder
A Study of Brenipatide in Participants With Opioid Use Disorder